Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Bear market mauls another small biotech as CEO, board members exit and execs bring out the axe, hunt deals
4 years ago
People
CRL appeal lands Ardelyx an FDA adcomm meeting for embattled CKD drug
4 years ago
R&D
FDA+
New York manufacturing supervisor gets 1-year sentence for stealing drugs for horse doping scheme
4 years ago
Pharma
Manufacturing
Vivo Capital pitches $60M to bring Arrowhead's RNAi meds to China via joint venture
4 years ago
Deals
China
Axolotls, chemical cocktails, and a new route for stem cell therapy — maybe
4 years ago
R&D
Discovery
Axsome expects migraine drug to be rejected as manufacturing issues arise
4 years ago
Pharma
FDA+
Black Diamond lays off 30% of its workforce and culls a drug from its 'MasterKey' chest
4 years ago
People
R&D
Faheem Hasnain acknowledges another setback for the Gossamer pipeline, but investors aren't panicking
4 years ago
R&D
'Results are unambiguous': Eliem's lead program fails and share price halves before opening bell
4 years ago
Startups
R&D
Serving as a 'gateway,' Cambridge venture investor closes $300M second fund
4 years ago
Financing
FDA warns small biotech Ocugen of potential $10K fines for failing to post trial results
4 years ago
FDA+
Nkarta reveals its first off-the-shelf NK cell data, showing multiple complete responses — shares soar
4 years ago
R&D
Cell/Gene Tx
Roche hit with another key R&D setback as oral SERD flops in breast cancer
4 years ago
R&D
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA
4 years ago
FDA+
New paper sheds fresh light on Tmunity's high-profile CAR-T deaths
4 years ago
R&D
Cell/Gene Tx
Endpoints 20 under 40; Verdict on PI3K; Regeneron goes discount shopping; $1.85B deal implodes; and more
4 years ago
Weekly
Pharma shells out more than $300K to brother of top Biden aide in 3 months
4 years ago
Pharma
Regeneron co-founders slow down compensation in 2021, netting just $13M combined after $270M in 2020
4 years ago
People
With contract manufacturing work in high demand, Netherlands CDMO lands new investment
4 years ago
Pharma
Manufacturing
Sisters act: Catholic nuns call for more transparency around the lobbying of several large pharma companies
4 years ago
Pharma
Moderna enlists mom influencers and more in push to raise awareness of little known CMV
4 years ago
Pharma
Marketing
FDA plots multi-day hearing to review 'dangling' accelerated approval that drugmaker refuses to pull
4 years ago
FDA+
Do patients and physicians weigh drug risks differently? FDA researchers plan to find out
4 years ago
Pharma
FDA+
Covid-19 roundup: WHO issues 'strong' recommendation for Pfizer's Paxlovid but wants more price transparency
4 years ago
Pharma
Coronavirus
First page
Previous page
534
535
536
537
538
539
540
Next page
Last page